Impact of the Dedicated Neurointensivists on the Outcome in Patients with Ischemic Stroke Based on the Linked Big Data for Stroke in Korea

• Published in: Journal of Korean medical science 2020, 35(21), , pp.1-9
• Main Authors: Kim, Tae Jung, Lee, Ji Sung, Yoon, Jae Sun, Oh, Mi Sun, Kim, Ji Woo, Jung, Keun Hwa, Yu, Kyung Ho, Lee, Byung Chul, Ko, Sang Bae, Yoon, Byung Woo
• Format: Article
• Language: English
• Subjects: Aged; Aged, 80 and over; Comorbidity; Databases, Factual; Female; Hospital Mortality; Humans; Intensive Care Units; Ischemic Stroke - epidemiology; Ischemic Stroke - mortality; Ischemic Stroke - pathology; Logistic Models; Male; Middle Aged; Odds Ratio; Original; Patient Discharge; Physician's Role; Registries; Republic of Korea - epidemiology; Risk Factors; Survival Analysis; Treatment Outcome; 의학일반
• ISSN: 1011-8934; 1598-6357
• DOI: 10.3346/jkms.2020.35.e135

Neurocritical care by dedicated neurointensivists may improve outcomes of critically ill patients with severe brain injury. In this study, we aimed to validate whether neurointensive care could improve the outcome in patients with critically ill acute ischemic stroke using the linked big dataset on stroke in Korea. We included 1,405 acute ischemic stroke patients with mechanical ventilator support in the intensive care unit after an index stroke. Patients were retrieved from linking the Clinical Research Center for Stroke Registry and the Health Insurance Review and Assessment Service data from the period between January 2007 and December 2014. The outcomes were mortality at discharge and at 3 months after an index stroke. The main outcomes were compared between the centers with and without dedicated neurointensivists. Among the included patients, 303 (21.6%) were admitted to the centers with dedicated neurointensivists. The patients treated by dedicated neurointensivists had significantly lower in-hospital mortality (18.3% vs. 26.8%, = 0.002) as well as lower mortality at 3-month (38.0% vs. 49.1%, < 0.001) than those who were treated without neurointensivists. After adjusting for confounders, a treatment without neurointensivists was independently associated with higher in-hospital mortality (odds ratio [OR], 1.59; 95% confidence intervals [CIs], 1.13-2.25; = 0.008) and 3-month mortality (OR, 1.48; 95% CIs, 1.12-1.95; = 0.005). Treatment by dedicated neurointensivists is associated with lower in-hospital and 3-month mortality using the linked big datasets for stroke in Korea. This finding stresses the importance of neurointensivists in treating patients with severe ischemic stroke.